Abstract 3175: CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer
In conclusion, we have shown that expression of CD38 plays an important role in MDSC biology by promoting an enhanced immunosuppressive capacity and a more immature phenotype in vivo. We have also detected an expansion of CD38-positive MDSCs in peripheral blood of advanced stage cancer patients and propose targeting CD38 in vivo as an approach to cancer therapy.Supported by NCI P01CA098101.Citation Format: Tatiana A. Karakasheva, Todd J. Waldron, Evgeniy Eruslanov, Ju-Seog Lee, Shaun O'Brien, Devraj Basu, Sunil Singhal, Fabio Malavasi, Anil K. Rustgi. CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3175. doi:10.1158/1538-7445.AM2015-3175
Source: Cancer Research - Category: Cancer & Oncology Authors: Karakasheva, T. A., Waldron, T. J., Eruslanov, E., Lee, J.-S., O'Brien, S., Basu, D., Singhal, S., Malavasi, F., Rustgi, A. K. Tags: Immunology Source Type: research
More News: Allergy & Immunology | Biology | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Esophagus Cancer | Genetics | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Transplants